DENGUE: EPIDEMIOLOGY PART II SCOTT B HALSTEAD, MD Director, Research PEDIATRIC DENGUE VACCINE INITIATIVE.

Slides:



Advertisements
Similar presentations
Immunity to Infectious Diseases
Advertisements

Disease emergence in immunocompromised populations Jamie Lloyd-Smith Penn State University.
Risk of invasive H. influenzae disease in patients with chronic renal failure: a call for vaccination? M. Ulanova, S. Gravelle, N. Hawdon, S. Malik, D.
Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent.
Dengue virus Huan-Yao Lei, Ph.D.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Immunity to Infectious Diseases BIOS 486A/586A K.J.Goodrum 2006.
Acquired Immunity Defends Against Infection of Body Cells and Fluids By: Jonah Harrington, Josh Yi.
DENGUE: EPIDEMIOLOGY PART 1
Virus, Vector and Epidemiology
Common Viral Haemorrhagic Fevers include:  R R R Rift valley fever, Dengue fever, Lassa fever,.  E E E Ebola and marburg viral disease.  B B
VIRAL HEAMORRHAGIC FEVERS Ahmed Mandil Prof of Epidemiology Dept of Family & Community Medicine College of Medicine, King Saud University.
Measles in Immunocompetent and Immunodeficient Hosts William Moss, MD, MPH Johns Hopkins Bloomberg School of Public Health FDA Blood Products Advisory.
Prof. Fatma Amer Medical Microbiology and Immunology, ZAGAZIG FACULTY OF Medicine, Egypt President of ISC/HWG President of ArAPUA In the Era of Direct.
Lecture outline The nomenclature of Immunology
Unit 10 Chapter 39 Immunity from Disease
Epidemiology in Community Health Care
HIV/AIDS as a Microcosm for the Study of Evolution.
Dengue hemorrhagic fever (DHF) Dengue shock syndrome (DSS) Probable risk factors for DHF –the infecting virus’s strain/serotype –the age of the patient.
The mechanism of ADE S 陳俊良. ADE has been proposed as an underlying pathogenic mechanism of DHF/ DSS. It often occurs in patients with second,
The role of cross-immunity and vaccines on the survival of less fit flu-strains Miriam Nuño Harvard School of Public Health Gerardo Chowell Los Alamos.
Case Study: Dengue Virus Virology 516 Fall 2007 Milette Mahinan, Suzi Sanchez, Olayinka Taiwo.
Peer Support: Francesca Peters + Reesha Ranat. A system of biological structures and process that exits to protect against disease Can be divided based.
Varicella Zoster Virus Herpesvirus (DNA) Primary infection results in varicella (chickenpox) Recurrent infection results in herpes zoster (shingles) Short.
Lecture outline Capture of antigens from sites of entry and display of antigens to T cells Function of MHC molecules as the peptide display molecules of.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis A Virus Division of Viral Hepatitis.
Lesson 4 Treatment for HIV / AIDS
OnSite Dengue Rapid Test.
HIV – FIV - LCMV Immune system + viruses Tricks of pers. V: T deletion / escape nAb delay / escape Re-encountered / persistent antigen maintains nAb (successful.
Overview Pediatric HIV Program & IMPAACT/ PACTG Vaccine Research Children’s National Medical Center, Washington, DC Dr.Hans ML Spiegel Director Special.
HIV-1 evolution in response to immune selection pressures
Multivalent pneumococcal vaccines can increase the transmissibility and virulence of non-vaccine strains Eleanor Watkins, Caroline Buckee, Bridget Penman,
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
Evolution and Human Health. I.Motivation Evolutionary principles can contribute to understanding of origin and treatment of human disease Evolutionary.
Joe Wiemels UCSF California Childhood Leukemia Study New research using archived DBS.
Evolution and Human Health – Chapter 14 - Flu virus evolution - Antibiotic resistance - Cancer as set of evolving population - Adaptative reasoning and.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
Host genetic diversity Genome-wide approaches. Affected sib analysis Take full sibs, preferably of the same sex should share many environmental variables.
Future directions in HIV basic science research The hunt for a cure.
G. S / AIH 2006 Graft-versus-Host disease Physiopathology Gérard Socié, MD PhD Hospital Saint Louis Translating experimental into clinical knowledge.
Dengue fever.
CONCEPTS OF INFLAMMATION AND THE IMMUNE RESPONSE.
1 INFLUENZA VIRUS. 2 ‘FLU’ True influenza –influenza virus A or influenza virus B (or influenza virus C infections - much milder) Febrile (showing signs.
GEO Meningitis Environmental Risk Consultative Meeting, sept 2007, WHO, Geneva Project : Long-term epidemiology of Meningococcal Meningitis in the.
starter CELL comparison Cell Natural Killer Cell B Lymphocyte
NK cells are part of the innate immune response
Immunology Review Part One Immune Responses Innate Immunity First line of defense in preventing foreign substances from entering body. Available at birth.
THE IMMUNE RESPONSES TO VIRUSES
Pathogenicity of Infectious Diseases. PATHOGENENVIRONMENT HOST DISEASE TRIAD Host-Parasite Interactions OTHER MICROBES Microbial Interactions.
Protection against Disease
FEVER DENGUE VIRUS: NO ONE IS SAFE Prepared by: Mohamed Abdul Gader.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
NUR 431.  A discipline that provides structure for systematically studying health, disease, and conditions related to health status ◦ Distribution of.
1 Considerations in the Pre- and Early Pandemic Use of Influenza Vaccine Jesse L. Goodman, MD, MPH Center for Biologics Evaluation and Research, VRBPAC,
Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the WHO Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005 R2.
EPIDEMIOLOGY OF INFNT DENGUE CASES ILLUMINATES SEROTYPE- SPECIFICITY IN THE INTERACTION BETWEEN IMMUNITY AND DISEASE AND CHANGES IN TRANSMISSION DYNAMICS.
DENGUE: EPIDEMIOLOGY PART II
Copyright © 2017 American Academy of Pediatrics.
Dengue Fever Amy Whitesell March 22, 2016.
FREQUENCIES AND PHENOTYPIC CHANGES OF DENDRITIC CELLS DURING ACUTE DENGUE VIRAL INFECTION Lertjuthaporn S1, Khowawisetsut L2, Keawvichit R1, Thitilertdecha.
Immunodeficiency (2 of 2)
Clinical Manifestations and Epidemiology
V. Disease Pathogenesis
Dengue Virus Infections Investigation Guideline
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,
Immunodeficiency (2 of 2)
Cellular and biochemical mediators of immune response By - (M-PHARM SEM-ii) Dept. of-PHARMACOLOGY.
RUBELLA Dr.T.V.Rao MD.
Dengue Antibodies, then Zika: A Fatal Sequence in Mice
Challenges, Consideration, and Progress
Presentation transcript:

DENGUE: EPIDEMIOLOGY PART II SCOTT B HALSTEAD, MD Director, Research PEDIATRIC DENGUE VACCINE INITIATIVE

EPIDEMIOLOGY Risk factors for severe disease. –Sequential dengue infection (includes antigenic structure of virus) –Race –Age –Host genetic factors –Nutritional status –Sex

Race –Caucasian & Asian vs African. At least 5:1 1,2 1.Guzman MG et al. AJTMH 42: , Halstead SB et al AJTMH 65:180, 2001

BLACKS ARE RELATIVELY RESISTANT TO SEVERE DENGUE ILLNESS A human resistance gene seems to explain the observation that while all dengue virus types circulate in Africa no DHF/DSS cases or outbreaks of DF have been reported.

RACE - SANTIAGO DE CUBA OUTBREAK, 1997

DENGUE NEUTRALIZING ANTIBODIES BY AGE IN 210 CHILDREN RESIDENT IN PORT AU PRINCE, HAITI, N =(46) (40) (36) (41) (27) (13) (10) (4)

AGE

DHF - EFFECT OF AGE, 1981 Cuba Outbreak GUZMAN MG et al. Int J Infect Dis 6:18, 2002

CAPILLARY FRAGILITY Gamble J et al. Biochem Soc Med Res Soc 98:211-6, 2000.

GENETIC ASSOCIATIONS Susceptibility Resistance HLA 1 : HLA-A*0207 HLA-A*0203 HLA-B*51 HLA-B*52 HLA A24 HLA A33 Vit D 2 : t allele/352 FcRγII 3 : DCSIGN 4 : CD 209 promoter TNFα 5 : TNF Loke H et al. JID 184: , Stephens HA et al. Tissue Antigens 60: , Loke H et al. AJTMH 67:102-6, Sakuntabthai A et al. Nat Genetics 37:507-13, Fernandez-Mestre MT et al. Tissue Ag 64:468-72, 2004

NUTRITIONAL STATUS

NUTRITIONAL STATUS OF DHF CASES vs. CONTROLS

Effect of nutritional status on dengue disease severity 1 Well nourished children: highly susceptible to severe disease Malnourished: protected against severe disease (protein-calorie malnutrition grade 2 and 3) 1. Thisyakorn U et al. CID 16: , 1993

SEX

SEX RATIOS BY DENGUE SYNDROME Bangkok Children’s Hospital,

DHF/DSS during primary dengue infections.

DHF/DSS in infants, identical to but more severe than DHF/DSS in children Higher case fatality rates, resuscitation requires more fluid per Kg body weight than in older children with 2 o infection. –Hung NT et al AJTMH 72:370, 2005 Circulating cytokines and cytokine levels during acute phase similar to those in older children during 2 o infection. –Hung NT et al JID 189:221, 2004

DSS in a 6 month-old infants with hepatomegaly. Vietnam

INFANT DHF/DSS

WHY DO MATERNAL ANTIBODIES ENHANCE DENGUE DISEASE? CENTRAL ROLE OF MACROPHAGES IN SUPPORTING DENGUE INFECTIONS IN HUMANS

Complexed with antibodies dengue viruses enter FcR-bearing cells with great efficiency. Dengue viruses are adapted to grow in dendritic cells, monocytes and macrophages.

IMMUNE ENHANCEMENT OF DENGUE INFECTION (Antibody-Dependent Enhancement) In the presence of dengue ADE antibody: increased rate of infection increase in the number of infected cells. increased production of viruses per cell.

ADE IN HUMAN DENGUE: DEN virus load and disease severity

DEN 3 VIREMIA ●--● DSS ▲- ▲DHF □--□ DF LIBRATY DH et al JID 185:1213, 2002

DISEASE SEVERITY CORRELATES WITH CELLULAR INFECTION

Schematic distribution of dengue 2 viruses in blood and tissues of 31 rhesus monkeys.

In endemic areas, DHF/DSS annual outbreaks differ in severity and size.

MYANMAR: VARYING CFR YEARCASESDEATHSCFR 19862, , , , , , ,

DENGUE VIRUSES, BANGKOK

WHY? Possible effect of –ADE –Heterotypic immunity –Replacement of serotypes –Clade extinctions These possibilities have been explored in mathematical models, most are based upon the hospital epidemiological data from Bangkok or all of Thailand.

EFFECT OF ADE ON EPIDEMIC CYCLES “Enhancement of infection may generate a complex and persistent cyclical or chaotic epidemic behavior ….and coexistence of mutiple strains” –Ferguson N et al. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of mutiple-strain pathogens.Proc Natl Acad Sci USA 96:790-4, 1999

EFFECT OF HETEROTYPIC IMMUNITY ON EPIDEMIC CYCLES 8-10 year epidemic cycles are accompanied by clade extinctions. Mathematical model suggests that heterotypic immunity is responsible. –Adams B et al PNAS 103: , 2006

SEROTYPE REPLACEMENT DENV -1 replaced DENV 2, 3, 4. Related to stochastic event due to low transmission in ? –Thu HM et al. Myanmar denge outbreak associated with displacement of serotypes 2, 3 and 4 by dengue 1. Emerg Infect Dis 10:693-7, 2004.

CLADE EXTINCTIONS DUE TO STOCHASTIC EVENTS In Myanmar, clades B and C of genotype I DENV -1 circulated with clade A genotype III during the 1990s. After 1998, clade A disappeared leaving only clades B and C. –Thu HM et al Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection. Virol 336:163-72, In Thailand, clades of DENV -3 circulating prior to 1992 disappeared and were replaced by two lineages with common ancestor. Earlier extinctions, 1963, 1973? –Wittke V et al. Extinction and rapid replacement of strains of dengue 3 virus during an interepidemic period. Virol 301: , 2002.